Jay Keasling
Fondateur chez Demetrix, Inc.
Profil
Jay D.
Keasling is the founder of Amyris, Inc. (2003), Codon Devices, Inc. (2004), Lygos, Inc. (2010), LS Dissolution, Inc. (2005), Biomia ApS (2022), Demetrix, Inc. (2015) where he is also a Director, and Napigen, Inc. (2016) where he is also the Chairman-Scientific Advisory Board.
Dr. Keasling is also the founder of ResVita Bio, Inc. He is currently the Chief Executive Officer at Joint Bioenergy Institute and the Associate Director-Laboratory Biosciences at Lawrence Berkeley National Laboratory.
Dr. Keasling's former job was as the Founding Director at the University of California, Berkeley.
He received his doctorate degree from the University of Michigan.
Postes actifs de Jay Keasling
| Sociétés | Poste | Début |
|---|---|---|
Lawrence Berkeley National Laboratory
 Lawrence Berkeley National Laboratory Miscellaneous Commercial ServicesCommercial Services Lawrence Berkeley National Laboratory engages on research of environmental studies, nanoscience, and quantitative biology, physics and nuclear energy. The lab is funded by the U.S. Department of Energy and managed by the University of California. It was founded in 1931 by Ernest Orlando Lawrence and is headquartered in Berkeley, CA. | Corporate Officer/Principal | - |
| Joint Bioenergy Institute | Directeur Général | - |
Demetrix, Inc.
 Demetrix, Inc. Pharmaceuticals: OtherHealth Technology Demetrix, Inc. manufactures natural medicines. The company was founded by William Haseltine and Jay Keasling in 2015 and is headquartered in Emeryville, CA. | Fondateur | 01/01/2015 |
Napigen, Inc.
 Napigen, Inc. Agricultural Commodities/MillingProcess Industries Napigen, Inc. is a biotechnology company that specializes in genome engineering of various organisms such as plants, microbes, and animals. The company is based in Wilmington, DE and Dr. Hajime Sakai has been the CEO since 2016. The company's technology targets mitochondria and chloroplasts, which are important for creating energy and producing biochemical molecules. The company's genome technology has broad applications in human and animal healthcare, agriculture, and industrial biotechnology. Napigen was founded in 2016 by a group of accomplished scientists, entrepreneurs, and investors including Dr. Hajime Sakai, Dr. Jay Keasling, Dr. Ganesh Kishore, and Dr. Roger Wyse. | Fondateur | 01/01/2016 |
Anciens postes connus de Jay Keasling
| Sociétés | Poste | Fin |
|---|---|---|
ResVita Bio, Inc.
 ResVita Bio, Inc. Miscellaneous Commercial ServicesCommercial Services ResVita Bio, Inc. is a company based in Berkeley, CA that aims to restore and maintain the vitality of the skin through the topical application of cellular therapies. ResVita Bio genetically programs living cells to repair disrupted skin and alleviate inflammation in various inflammatory skin diseases, including Netherton syndrome, atopic dermatitis, acne rosacea, and psoriasis. The company has received several awards, including the Bakar Innovation Fellowship, NIAMS SBIR Award, NIAID SBIR Award, and the AbbVie Golden Ticket at UC Berkeley's Bakar Labs. ResVita Bio is developing a safe and versatile skin probiotic platform through synthetic biology and metabolic engineering to continuously deliver therapies that directly treat inflammatory skin diseases, including Netherton syndrome, atopic dermatitis, chronic wound infection, and psoriasis. The company was founded by Amin Zargar and Jay D. Keasling, with Amin Zargar serving as the CEO since incorporation. | Fondateur | - |
| AMYRIS, INC. | Fondateur | - |
Codon Devices, Inc.
 Codon Devices, Inc. Pharmaceuticals: MajorHealth Technology Codon Devices, Inc. produces pharmaceuticals and biorefineries for the production of industrial chemicals and bio-energy. The firm designs and constructs biological components such as enzymes, biopharmaceuticals, and cell lines for improved function. Its customers include the biotechnology, pharmaceutical, and agriculture sectors. The company was founded by Noubar B. Afeyan, George Church, Drew Endy, Joseph M. Jacobson and Jay Keasling in 2004 and is headquartered in Cambridge, MA. | Fondateur | - |
Lygos, Inc.
 Lygos, Inc. Chemicals: Major DiversifiedProcess Industries Lygos, Inc. engages in the development of full-stack biological engineering platform. Its platform focuses on organic acid specialty chemicals and bio-monomers. The company was founded by Eric Steen, Jeffrey Dietrich, Jay D. Keasling, Leonard Katz, and J. L. Clem Fortman in 2010 and is headquartered in Berkeley, CA. | Fondateur | - |
Formation de Jay Keasling
| University of Michigan | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AMYRIS, INC. | Process Industries |
| Entreprise privées | 8 |
|---|---|
Codon Devices, Inc.
Codon Devices, Inc. Pharmaceuticals: MajorHealth Technology Codon Devices, Inc. produces pharmaceuticals and biorefineries for the production of industrial chemicals and bio-energy. The firm designs and constructs biological components such as enzymes, biopharmaceuticals, and cell lines for improved function. Its customers include the biotechnology, pharmaceutical, and agriculture sectors. The company was founded by Noubar B. Afeyan, George Church, Drew Endy, Joseph M. Jacobson and Jay Keasling in 2004 and is headquartered in Cambridge, MA. | Health Technology |
Lygos, Inc.
Lygos, Inc. Chemicals: Major DiversifiedProcess Industries Lygos, Inc. engages in the development of full-stack biological engineering platform. Its platform focuses on organic acid specialty chemicals and bio-monomers. The company was founded by Eric Steen, Jeffrey Dietrich, Jay D. Keasling, Leonard Katz, and J. L. Clem Fortman in 2010 and is headquartered in Berkeley, CA. | Process Industries |
Lawrence Berkeley National Laboratory
Lawrence Berkeley National Laboratory Miscellaneous Commercial ServicesCommercial Services Lawrence Berkeley National Laboratory engages on research of environmental studies, nanoscience, and quantitative biology, physics and nuclear energy. The lab is funded by the U.S. Department of Energy and managed by the University of California. It was founded in 1931 by Ernest Orlando Lawrence and is headquartered in Berkeley, CA. | Commercial Services |
LS Dissolution, Inc.
 LS Dissolution, Inc. Chemicals: Major DiversifiedProcess Industries LS Dissolution, Inc. engages in the production of petroleum replacement products and industrial chemicals. It offers chemical and fuel products. The company was founded by George M. Church, Christopher Somerville, Noubar B. Afeyan and Jay D. Keasling in 2005 and is headquartered in South San Francisco, CA. | Process Industries |
| Joint Bioenergy Institute | |
Demetrix, Inc.
Demetrix, Inc. Pharmaceuticals: OtherHealth Technology Demetrix, Inc. manufactures natural medicines. The company was founded by William Haseltine and Jay Keasling in 2015 and is headquartered in Emeryville, CA. | Health Technology |
Napigen, Inc.
Napigen, Inc. Agricultural Commodities/MillingProcess Industries Napigen, Inc. is a biotechnology company that specializes in genome engineering of various organisms such as plants, microbes, and animals. The company is based in Wilmington, DE and Dr. Hajime Sakai has been the CEO since 2016. The company's technology targets mitochondria and chloroplasts, which are important for creating energy and producing biochemical molecules. The company's genome technology has broad applications in human and animal healthcare, agriculture, and industrial biotechnology. Napigen was founded in 2016 by a group of accomplished scientists, entrepreneurs, and investors including Dr. Hajime Sakai, Dr. Jay Keasling, Dr. Ganesh Kishore, and Dr. Roger Wyse. | Process Industries |
ResVita Bio, Inc.
ResVita Bio, Inc. Miscellaneous Commercial ServicesCommercial Services ResVita Bio, Inc. is a company based in Berkeley, CA that aims to restore and maintain the vitality of the skin through the topical application of cellular therapies. ResVita Bio genetically programs living cells to repair disrupted skin and alleviate inflammation in various inflammatory skin diseases, including Netherton syndrome, atopic dermatitis, acne rosacea, and psoriasis. The company has received several awards, including the Bakar Innovation Fellowship, NIAMS SBIR Award, NIAID SBIR Award, and the AbbVie Golden Ticket at UC Berkeley's Bakar Labs. ResVita Bio is developing a safe and versatile skin probiotic platform through synthetic biology and metabolic engineering to continuously deliver therapies that directly treat inflammatory skin diseases, including Netherton syndrome, atopic dermatitis, chronic wound infection, and psoriasis. The company was founded by Amin Zargar and Jay D. Keasling, with Amin Zargar serving as the CEO since incorporation. | Commercial Services |